Activatable molecular probes for cancer imaging

Current Topics in Medicinal Chemistry

Volumn 10, Issue 11, 2010, Pages 1135-1144

  Lee, Seulki ^a   Xie, Jin ^a   Chen, Xiaoyuan ^a  

^a NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; QUANTUM DOT;

ARTICLE; CANCER DIAGNOSIS; FLUORESCENCE RESONANCE ENERGY TRANSFER; MACROMOLECULE; MOLECULAR PROBE;

HUMANS; MOLECULAR PROBE TECHNIQUES; MOLECULAR PROBES; NEOPLASMS;

EID: 77955643822     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802610791384270     Document Type: Article

References (71)

1. Weissleder, R.; Mahmood, U. Molecular imaging. Radiology, 2001, 219(2), 316-333.
2. Hoffman, J. M.; Gambhir, S. S. Molecular imaging: the vision and opportunity for radiology in the future. Radiology, 2007, 244(1), 39-47.
3. Cai, W.; Chen, X. Nanoplatforms for targeted molecular imaging in living subjects. Small, 2007, 3(11), 1840-1854.
4. Lee, S.; Chen, X. Dual-modality probes for in vivo molecular imaging. Mol. Imaging, 2009, 8(2), 87-100.
5. Lee, S.; Xie, J.; Chen, X. Peptide-based probes for targeted molecular imaging. Biochemistry, 49(7), 1364-1376.
6. Lee, S.; Park, K.; Kim, K.; Choi, K.; Kwon, I. C. Activatale imaging probes with amplified fluorescent signals. Chem. Commun., (Camb) 2008, (36), 4250-4260.
7. Elias, D. R.; Thorek, D. L.; Chen, A. K.; Czupryna, J.; Tsourkas, A. In vivo imaging of cancer biomarkers using activatable molecular probes. Cancer Biomark, 2008, 4(6), 287-305.
8. Sekar, R. B.; Periasamy, A. Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J. Cell Biol., 2003, 160(5), 629-633.
9. Johansson, M. K.; Cook, R. M. Intramolecular dimers: a new esign strategy for fluorescence-quenched probes. Chemistry, 2003, 9(15), 3466-71.
10. Yun, C. S.; Javier, A.; Jennings, T.; Fisher, M.; Hira, S.; Peterson, S.; Hopkins, B.; Reich, N. O.; Strouse, G. F. Nanometal surface energy transfer in optical rulers, breaking the FRET barrier. J. Am. Chem. Soc., 2005, 127(9), 3115-9.
11. Weissleder, R.; Ntziachristos, V. Shedding light onto live molecular targets. Nat. Med., 2003, 9(1), 123-128.
12. Frangioni, J. V. In vivo near-infrared fluorescence imaging. Curr. Opin. Chem.Biol., 2003, 7(5), 626-634.
13. Egeblad, M.; Werb, Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer, 2002, 2(3), 161-74.
14. Pham, W.; Choi, Y.; Weissleder, R.; Tung, C. H. Developing a peptide-based near-infrared molecular probe for protease sensing. Bioconjug. Chem., 2004, 15(6), 1403-1407.
15. Pham, W.; Lai, W. F.; Weissleder, R.; Tung, C. H. High efficiency synthesis of a bioconjugatable near-infrared fluorochrome. Bioconjug Chem., 2003, 14(5), 1048-1051.
16. Johansson, M. K.; Cook, R. M.; Xu, J.; Raymond, K. N. Time gating improves sensitivity in energy transfer assays with terbium chelate/dark quencher oligonucleotide probes. J. Am. Chem. Soc., 2004, 126(50), 16451-16455.
17. Lee, S.; Park, K.; Lee, S. Y.; Ryu, J. H.; Park, J. W.; Ahn, H. J.; Kwon, I. C.; Youn, I. C.; Kim, K.; Choi, K. Dark quenched matrix metalloproteinase fluorogenic probe for imaging osteoarthritis development in vivo. Bioconjug Chem., 2008, 19(9), 1743-1747.
18. Jiang, T.; Olson, E. S.; Nguyen, Q. T.; Roy, M.; Jennings, P. A.; Tsien, R. Y. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc. Natl. Acad. Sci. USA, 2004, 101(51), 17867-17872.
19. Olson, E. S.; Aguilera, T. A.; Jiang, T.; Ellies, L. G.; Nguyen, Q. T.; Wong, E. H.; Gross, L. A.; Tsien, R. Y. In vivo characterization of activatable cell penetrating peptides for targeting protease activity in cancer. Integr Biol., (Camb) 2009, 1(5-6), 382-393.
20. Blum, G.; Mullins, S. R.; Keren, K.; Fonovic, M.; Jedeszko, C.; Rice, M. J.; Sloane, B. F.; Bogyo, M. Dynamic imaging of protease activity with fluorescently quenched activity-based probes. Nat. Chem. Biol., 2005, 1(4), 203-209.
21. Blum, G.; von Degenfeld, G.; Merchant, M. J.; Blau, H. M.; Bogyo, M. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. Nat. Chem .Biol., 2007, 3(10), 668-677.
22. Fonovic, M.; Bogyo, M. Activity based probes for proteases: applications to biomarker discovery, molecular imaging and drug screening. Curr. Pharm. Des., 2007, 13(3), 253-261.
23. Edgington, L. E.; Berger, A. B.; Blum, G.; Albrow, V. E.; Paulick, M. G.; Lineberry, N.; Bogyo, M. Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes. Nat. Med., 2009, 15(8), 967-973.
24. Riedl, S. J.; Shi, Y. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol., 2004, 5(11), 897-907.
25. Fischer, U.; Schulze-Osthoff, K. New approaches and therapeutics targeting apoptosis in disease. Pharmacol. Rev., 2005, 57(2), 187-215.
26. Grutter, M. G. Caspases: key players in programmed cell death. Curr. Opin. Struct. Biol., 2000, 10(6), 649-655.
27. Pham, W.; Weissleder, R.; Tung, C. H. An azulene dimer as a nearinfrared quencher. Angew. Chem. Int. Ed. Engl., 2002, 41(19), 3659-62, 3519.
28. Zhang, Z.; Fan, J.; Cheney, P. P.; Berezin, M. Y.; Edwards, W. B.; Akers, W. J.; Shen, D.; Liang, K.; Culver, J. P.; Achilefu, S. Activatable molecular systems using homologous near-infrared fluorescent probes for monitoring enzyme activities in vitro, in cellulo, and in vivo. Mol. Pharm., 2009, 6(2), 416-427.
29. Bullok, K.; Piwnica-Worms, D. Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J. Med. Chem., 2005, 48(17), 5404-5407.
30. Maxwell, D.; Chang, Q.; Zhang, X.; Barnett, E. M.; Piwnica-Worms, D. An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug. Chem., 2009, 20(4), 702-709.
31. Barnett, E. M.; Zhang, X.; Maxwell, D.; Chang, Q.; Piwnica-Worms, D. Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model. Proc. Natl. Acad. Sci. USA, 2009, 106(23), 9391-9396.
32. Kim, J.-H.; Park, K.; Nam, H. Y.; Lee, S.; Kim, K.; Kwon, I. C. Polymers for bioimaging. Prog. Polymer Sci., 32(8-9), 1031-1053.
33. Park, J. H.; Lee, S.; Kim, J.-H.; Park, K.; Kim, K.; Kwon, I. C. Polymeric nanomedicine for cancer therapy. Prog. Polym. Sci., 2008, 33(1), 113-137.
34. Weissleder, R.; Tung, C. H.; Mahmood, U.; Bogdanov, A. Jr. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol., 1999, 17(4), 375-378.
35. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 1986, 46(12 Pt 1), 6387-6392.
36. Bremer, C.; Tung, C. H.; Bogdanov, A. Jr.; Weissleder, R. Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. Radiology, 2002, 222(3), 814-818.
37. Tung, C. H.; Bredow, S.; Mahmood, U.; Weissleder, R. Preparation of a cathepsin D sensitive near-infrared fluorescence probe for imaging. Bioconjug. Chem., 1999, 10(5), 892-896.
38. Tung, C. H.; Mahmood, U.; Bredow, S.; Weissleder, R. In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res., 2000, 60(17), 4953-4958.
39. Bremer, C.; Tung, C. H.; Weissleder, R. In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat. Med., 2001, 7(6), 743-748.
40. Wunder, A.; Tung, C. H.; Muller-Ladner, U.; Weissleder, R.; Mahmood, U. In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum., 2004, 50(8), 2459-2465.
41. Deguchi, J. O.; Aikawa, M.; Tung, C. H.; Aikawa, E.; Kim, D. E.;Ntziachristos, V.; Weissleder, R.; Libby, P. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo. Circulation, 2006, 114(1), 55-62.
42. Shah, K.; Tung, C. H.; Chang, C. H.; Slootweg, E.; O'Loughlin, T.; Breakefield, X. O.; Weissleder, R. In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas. Cancer Res., 2004, 64(1), 273-278.
43. Samad, A.; Alam, M. I.; Saxena, K. Dendrimers: a class of polymers in the nanotechnology for the delivery of active pharmaceuticals. Curr. Pharm. Des., 2009, 15(25), 2958-2959.
44. Scherer, R. L.; VanSaun, M. N.; McIntyre, J. O.; Matrisian, L. M. Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon. Mol. Imaging, 2008, 7(3), 118-1131.
45. Nguyen, Q. T.; Olson, E. S.; Aguilera, T. A.; Jiang, T.; Scadeng, M.; Ellies, L. G.; Tsien, R. Y. Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival. Proc. Natl. Acad. Sci. USA, 2010, 107(9), 4317-4322
46. Galande, A. K.; Hilderbrand, S. A.; Weissleder, R.; Tung, C. H. Enzyme-targeted fluorescent imaging probes on a multiple antigenic peptide core. J. Med. Chem., 2006, 49(15), 4715-4720
47. Kyeongsoon, P.; Seulki, L.; Eunah, K.; Kwangmeyung, K.; Kuiwon, C.; Ick Chan, K. New generation of multifunctional nanoparticles for cancer imaging and therapy. Adv. Funct. Mater., 2009, 19(10), 1553-1566.
48. Kim, K.; Lee, M.; Park, H.; Kim, J. H.; Kim, S.; Chung, H.; Choi, K.; Kim, I. S.; Seong, B. L.; Kwon, I. C. Cell-permeable and biocompatible polymeric nanoparticles for apoptosis imaging. J. Am. Chem. Soc., 2006, 128(11), 3490-3491.
49. Lee, S.; Ryu, J. H.; Park, K.; Lee, A.; Lee, S. Y.; Youn, I. C.; Ahn, C. H.; Yoon, S. M.; Myung, S. J.; Moon, D. H.; Chen, X.; Choi, K.; Kwon, I. C.; Kim, K. Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo. Nano Lett., 2009, 9 (12), 4412-4416.
50. Park, K.; Kim, J. H.; Nam, Y. S.; Lee, S.; Nam, H. Y.; Kim, K.; Park, J. H.; Kim, I. S.; Choi, K.; Kim, S. Y.; Kwon, I. C. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles. J. Control. Release, 2007, 122(3), 305-314.
51. Wu, A. M.; Olafsen, T. Antibodies for molecular imaging of cancer. Cancer J., 2008, 14 (3), 191-197.
52. Barrett, T.; Koyama, Y.; Hama, Y.; Ravizzini, G.; Shin, I. S.; Jang, B. S.; Paik, C. H.; Urano, Y.; Choyke, P. L.; Kobayashi, H. In vivo diagnosis of epidermal growth factor receptor expression using molecular imaging with a cocktail of optically labeled monoclonal antibodies. Clin. Cancer Res., 2007, 13(22 Pt 1), 6639-6648.
53. Ogawa, M.; Kosaka, N.; Choyke, P. L.; Kobayashi, H. In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. Cancer Res., 2009, 69(4), 1268-1272.
54. Tadatsu, Y.; Muguruma, N.; Ito, S.; Tadatsu, M.; Kusaka, Y.; Okamoto, K.; Imoto, Y.; Taue, H.; Sano, S.; Nagao, Y. Optimal labeling condition of antibodies available for immunofluorescece endoscopy. J. Med. Invest, 2006, 53(1-2), 52-60.
55. Urano, Y.; Asanuma, D.; Hama, Y.; Koyama, Y.; Barrett, T.; Kamiya, M.; Nagano, T.; Watanabe, T.; Hasegawa, A.; Choyke, P. L.; Kobayashi, H. Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes. Nat. Med., 2009, 15(1), 104-109.
56. Jaiswal, J. K.; Mattoussi, H.; Mauro, J. M.; Simon, S. M. Longterm multiple color imaging of live cells using quantum dot bioconjugates. Nat. Biotechnol., 2003, 21(1), 47-51.
57. Medintz, I. L.; Mattoussi, H. Quantum dot-based resonance energy transfer and its growing application in biology. Phys. Chem. Chem. Phys., 2009, 11(1), 17-45.
58. Dubertret, B.; Calame, M.; Libchaber, A. J. Single-mismatch detection using gold-quenched fluorescent oligonucleotides. Nat. Biotechnol., 2001, 19(4), 365-370.
59. Cai, W.; Shin, D. W.; Chen, K.; Gheysens, O.; Cao, Q.; Wang, S. X.; Gambhir, S. S.; Chen, X. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett., 2006, 6(4), 669-676.
60. Algar, W. R.; Krull, U. J. Quantum dots as donors in fluorescence resonance energy transfer for the bioanalysis of nucleic acids, proteins, and other biological molecules. Anal. Bioanal. Chem., 2008, 391(5), 1609-1618.
61. Medintz, I. L.; Clapp, A. R.; Brunel, F. M.; Tiefenbrunn, T.; Uyeda, H. T.; Chang, E. L.; Deschamps, J. R.; Dawson, P. E.; Mattoussi, H. Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates. Nat. Mater., 2006, 5(7), 581-589.
62. Medintz, I. L.; Clapp, A. R.; Mattoussi, H.; Goldman, E. R.; Fisher, B.; Mauro, J. M. Self-assembled nanoscale biosensors based on quantum dot FRET donors. Nat. Mater., 2003, 2 (9), 630-638.
63. Shi, L.; De Paoli, V.; Rosenzweig, N.; Rosenzweig, Z. Synthesis and application of quantum dots FRET-based protease sensors. J. Am. Chem. Soc., 2006, 128(32), 10378-10379.
64. Boeneman, K.; Mei, B. C.; Dennis, A. M.; Bao, G.; Deschamps, J. R.; Mattoussi, H.; Medintz, I. L. Sensing caspase 3 activity with quantum dot-fluorescent protein assemblies. J. Am. Chem. Soc., 2009, 131(11), 3828-3829.
65. Xia, Z.; Rao, J. Biosensing and imaging based on bioluminescence resonance energy transfer. Curr. Opin. Biotechnol., 2009, 20(1), 37-44.
66. So, M. K.; Xu, C.; Loening, A. M.; Gambhir, S. S.; Rao, J. Selfilluminating quantum dot conjugates for in vivo imaging. Nat. Biotechnol., 2006, 24(3), 339-343.
67. Yao, H.; Zhang, Y.; Xiao, F.; Xia, Z.; Rao, J. Quantum dot/bioluminescence resonance energy transfer based highly sensitive detection of proteases. Angew. Chem. Int. Ed. Engl., 2007, 46(23), 4346-4349.
68. Boisselier, E.; Astruc, D. Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chem. Soc. Rev., 2009, 38 (6), 1759-1782.
69. Lee, S.; Cha, E. J.; Park, K.; Lee, S. Y.; Hong, J. K.; Sun, I. C.; Kim, S. Y.; Choi, K.; Kwon, I. C.; Kim, K.; Ahn, C. H. A nearinfrared-fluorescence-quenched gold-nanoparticle imaging probe for in vivo drug screening and protease activity determination. Angew. Chem. Int. Ed. Engl., 2008, 47(15), 2804-2807.
70. Lee, H.; Lee, K.; Kim, I. K.; Park, T. G. Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. Biomaterials, 2008, 29, (35), 4709-4718.
71. Liu, D.; Pearlman, E.; Diaconu, E.; Guo, K.; Mori, H.; Haqqi, T.; Markowitz, S.; Willson, J.; Sy, M. S. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA, 1996, 93, (15), 7832-7837.